Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

Following closing of its transaction with Telix Pharmaceuticals, ImaginAb, Inc. will be focused on developing its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials ...

The Company’s fourth quarter and full-year 2024 financial and operational results are preliminary and are subject to the completion of the Company’s 2024 audit. Audited full-year 2024 and unaudited ...

E Ink (8069.TWO), the originator, pioneer, and global commercial leader in ePaper technology, today announced they will be ...

At CES 2025, TESSAN showcased its relentless pursuit of technological innovation and enhanced user experience, engaging with ...

LAS VEGAS, Jan. 12, 2025 /PRNewswire/ -- CES ® 2025, the most powerful tech event in the world, welcomed over 141,000 ...

The Cx20 is powered by a Hexa-core Intel® i3-1215U processor, reaching speeds up to 4.4GHz. With compatibility for Windows 11 ...

LAS VEGAS, Jan. 11, 2025 /PRNewswire/ -- Think Academy debuted its Thinkpal tablet at CES 2025 and has won a TechRadar Pro ...

吳靜怡提到，李文宗、許芷瑜難道都不是因為柯文哲而成了共犯嗎？一個早就能享受台商退休的老同學，另一個名門世家的後代。民眾黨，怎麼不為他們喊冤？他們的家庭也無法好好過年。

TORONTO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Northfield Capital Corporation (TSX-V: NFD.A) (“ Northfield ”) announced today its intention to effect a normal course issuer bid through the facilities of ...

Associated Capital Group, Inc. (“AC” or the “Company”) (NYSE: AC), announced today a preliminary range for its fourth quarter book value of $42.04 to $42.24 per share. These estimates reflect the $2 ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...